Australian Clinical Labs Limited (ACL)
Market Closed
ASX ASX Primary 716.69M Market Cap
- P/E Ratio
0% Div Yield
578,371 Volume
- Eps
Summary
ACL closed yesterday higher, an increase of 0.67% from Friday's close, completing a monthly decrease of -0.33%. Over the past 12 months, ACL stock lost -19.14%.
ACL pays dividends to its shareholders, with the most recent payment made on Sep 27, 2024. The next announced payment will be in In 2 weeks on Apr 16, 2025 for a total of A$0.035.
The last earnings report, released on Feb 26, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on ASX (AUD).
Want to track ACL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Australian Clinical Labs Limited Dividends
| ACL 5 days ago Estimated | Final | A$0.04 Per Share |
| ACL 5 days ago Announced | Final | A$0.04 Per Share |
| ACL 6 months ago Paid | Interim | A$0.09 Per Share |
| ACL 28 Mar 2024 Paid | Final | A$0.03 Per Share |
| ACL 14 Sep 2023 Paid | Interim | A$0.07 Per Share |
| ACL 27 Mar 2023 Paid | Final | A$0.07 Per Share |
Australian Clinical Labs Limited Earnings
| 26 Feb 2025 Date | | - Cons. EPS | - EPS |
| 22 Oct 2024 Date | | - Cons. EPS | - EPS |
| 29 Aug 2024 Date | | - Cons. EPS | - EPS |
| 21 Aug 2024 Date | | - Cons. EPS | - EPS |
| 28 Feb 2024 Date | | - Cons. EPS | - EPS |
| ACL 5 days ago Estimated | Final | A$0.04 Per Share |
| ACL 5 days ago Announced | Final | A$0.04 Per Share |
| ACL 6 months ago Paid | Interim | A$0.09 Per Share |
| ACL 28 Mar 2024 Paid | Final | A$0.03 Per Share |
| ACL 14 Sep 2023 Paid | Interim | A$0.07 Per Share |
| ACL 27 Mar 2023 Paid | Final | A$0.07 Per Share |
| 26 Feb 2025 Date | | - Cons. EPS | - EPS |
| 22 Oct 2024 Date | | - Cons. EPS | - EPS |
| 29 Aug 2024 Date | | - Cons. EPS | - EPS |
| 21 Aug 2024 Date | | - Cons. EPS | - EPS |
| 28 Feb 2024 Date | | - Cons. EPS | - EPS |
Australian Clinical Labs Limited (ACL) FAQ
On which exchange is it traded?
Australian Clinical Labs Limited is listed on ASX.
What is its stock symbol?
The ticker symbol is ACL.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 716.69M.
Has Australian Clinical Labs Limited ever had a stock split?
No, there has never been a stock split.
Australian Clinical Labs Limited Profile
| Software - Application Industry | Technology Sector | Ms. Tess Mattisson CEO | ASX Exchange | AU0000148496 ISIN |
| Sweden Country | 16 Employees | 27 Mar 2025 Last Dividend | - Last Split | - IPO Date |
Overview
Zaplox AB is a pioneering company in the hospitality industry, offering innovative mobile key solutions on a global scale. Founded in 2010 and with its headquarters in Lund, Sweden, Zaplox caters to hotels and hospitality facilities, enhancing guest experience through digital transformation. By focusing on convenience, efficiency, and the promotion of contactless operations, Zaplox has positioned itself as a significant player in redefining hospitality services for the modern era.
Products and Services
- Zaplox Mobile Guest App with Mobile Keys: This flagship product streamlines the guest experience by facilitating mobile check-in/check-out and payment processes. By incorporating mobile keys, the app ensures guests can access their rooms and other hotel facilities securely and conveniently, directly from their smartphone, eliminating the need for physical keycards.
- Zaplox Software Development Kit (SDK): Catering to businesses that wish to customize their guest experience, the Zaplox SDK offers extensive mobile access integrations. This includes seamless integration with Property Management Systems (PMS) and lock systems, enabling hotels to enhance their existing applications with mobile key functionality and ensuring a more integrated, user-friendly service.
- Zaplox Kiosk: Addressing the growing demand for self-service options in the hospitality industry, the Zaplox Kiosk facilitates a fully automated, contactless check-in and checkout process. This solution not only improves operational efficiency for the hotel but also caters to the modern guest's desire for convenience, speed, and minimal human contact.
Contact Information
Address: IDEON Gateway
Phone: -
Website: https://www.zaplox.com
2025 © Marketlog. All Rights Reserved.
